Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.3250
-0.0085 (-2.55%)
At close: Jul 18, 2025, 4:00 PM
0.3330
+0.0080 (2.46%)
After-hours: Jul 18, 2025, 6:39 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $8.15 million as of July 18, 2025. Its market cap has decreased by -87.92% in one year.
Market Cap
8.15M
Enterprise Value
7.56M
1-Year Change
-87.92%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $8.15M, a decrease of -87.66%. That is a compound annual growth rate of -63.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 8.36M | -68.55% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 707.11B |
| Johnson & Johnson | 394.57B |
| AbbVie | 335.53B |
| Novo Nordisk | 301.36B |
| UnitedHealth Group | 266.16B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 228.84B |
| AstraZeneca | 217.99B |